Latest Imaging SPECT System Evaluation Phase 1 (LISSE1)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04704349|
Recruitment Status : Recruiting
First Posted : January 11, 2021
Last Update Posted : January 11, 2021
|Condition or disease||Intervention/treatment||Phase|
|Rheumatic Disease Neoplasms Parathyroid Diseases Pulmonary Embolism Heart Diseases Thyroid Diseases Kidney Diseases Dementia Parkinsonian Disorders||Radiation: Scintigraphy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||85 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||All patients will undergo scintigraphy on 2 distinct devices and the images obtained will be compared.|
|Masking:||None (Open Label)|
|Official Title:||Latest Imaging SPECT System Evaluation Phase 1|
|Actual Study Start Date :||October 5, 2020|
|Estimated Primary Completion Date :||October 2021|
|Estimated Study Completion Date :||October 2021|
Experimental: Scintigraphy acquisitions
All patients will undergo scintigraphy on 2 distinct devices and the images obtained will be compared.
The scintigraphy of the patients will be carried out on 2 distinct devices and the images obtained will be compared.
- Rate of images with a score greater than or equal to 4 [ Time Frame: Day 0 ]Rate of images obtaining a score greater than or equal to 4 in visual image quality analysis on a 5-point LIKERT scale.
- collimator performance [ Time Frame: Day 0 ]Physical measurements of collimator performance on test object.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04704349
|Contact: Aurélie DESPUJOLSfirstname.lastname@example.org|
|Contact: Elodie POUGOUE TOUKOemail@example.com|
|Principal Investigator:||Gilles METRARD, Dr||CHR Orléans|